Clinical Trials Logo
  1. Home
  2. Exercise Performance
  3. NCT04837898
  4. Details
NCT04837898 Clinical Trial

Haskap and Endurance Running Performance

Exercise Performance Clinical Trial

Official title:
The Influence of Haskap Berry on Exercise Performance

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04837898
Other study ID # 26514
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 12, 2021
Est. completion date December 8, 2021

Study information
Verified date April 2021
Source Northumbria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Description:

Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the intervention on aerobic performance parameters. Other performance parameters such as blood lactate, heart rate, ratings of perceived exertion and respiratory variables will also be monitored throughout the various elements of the exercise trials.

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date December 8, 2021
Est. primary completion date November 8, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - healthy non-smoking males - completed a 5 km run (in less than 25 minutes) within the 6 weeks prior to the study Exclusion Criteria: - female - allergies to fruit or dairy, currently taking any nutritional supplements (e.g. vitamins, antioxidant, herbal or sports enhancing supplements) or medication that might affect the study outcome - history of gastrointestinal, renal or cardiovascular disease

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• Haskapa
Haskapa Ltd, Oxford, UK
• Placebo
isocaloric to the haskap powder

Locations
Country Name City State
United Kingdom Northumbria University Newcastle Upon Tyne

Sponsors (3)
Lead Sponsor Collaborator
Northumbria University Haskapa Ltd, Mibelle Group Biochemistry

Country where clinical trial is conducted

United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary 5km time trial time to complete the trial (seconds) Change from baseline at 7 days
Primary V?O2peak test time to exhaustion (seconds) Change from baseline at 7 days
Secondary Blood lactate response during submaximal tests, maximal and time trial lactate (mmol/L) Change from baseline at 7 days
Secondary rating of perceived exertion during submaximal tests, maximal and time trial RPE (/20) Change from baseline at 7 days
Secondary heart rate during submaximal tests, maximal and time trial (BPM) Change from baseline at 7 days
Secondary VO2 during submaximal tests, maximal tests (oxygen uptake - relative ml/kg/min and absolute l/min) Change from baseline at 7 days
See also
  Status Clinical Trial Phase
Completed NCT03616093 - The Impact of Acute (2 h) and Short-term (4 Days) Nitrate Supplementation in the Form of Red Beet Root Juice on Intense Intermittent Exercise Performance. N/A
Completed NCT03294642 - Potato Ingestion and Time-trial Performance N/A
Completed NCT05831527 - An Exploratory Investigation of a Supplement to Promote Gut Health N/A
Not yet recruiting NCT03954665 - Ketone Supplementation and Exercise Performance N/A
Completed NCT04263246 - Medium-Term Supplementation With Herbal Extract for Exercise Performance and Antioxidant Status N/A
Not yet recruiting NCT05428228 - Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults N/A
Recruiting NCT04004676 - Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise N/A
Completed NCT03565523 - The Effect of Dietary Nitrate Supplementation on Linear Running Sprint Performance, Agility and Vertical Jump Performance in a Rested and Fatigued State N/A
Recruiting NCT06066606 - U-LABA/ICS Effects on Exercise Performance, Vilanterol N/A
Recruiting NCT06077019 - Role of Lung Function for Exercise Capacity in Well-trained Individuals N/A
Recruiting NCT06067100 - U-LABA/ICS Effects on Exercise Performance, Indacaterol N/A
Completed NCT05559372 - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes N/A
Completed NCT03525561 - Acetazolamide and Exercise Performance at Altitude Early Phase 1
Completed NCT03929575 - Effects of Herbal Supplements on Endurance Exercise Performance N/A
Completed NCT03977246 - Effect of Open-placebo Intervention on Cycling Performance N/A
Completed NCT03686982 - The Impact of Supplementation With Novel Prototype Nutrition Bar on Nitric Oxide Bioavailability and Measures of Athlete Performance N/A
Completed NCT06165523 - Kefir Versus Milk on Time-Trial Performance in Masters Athletes N/A
Completed NCT06390670 - The Effect of Colostrum Bovinum Supplementation in Endurance Athletes Phase 2/Phase 3
Completed NCT05586295 - Vitamin B Complex Improved Exercise Performance and Anti-fatigue N/A
Recruiting NCT06374641 - The Effects of a Novel Mitochondrial Substrate Supplement on Exercise Performance and Cognitive Function N/A